We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Tadalafil for Pulmonary Hypertension
FDA Approves Tadalafil for Pulmonary Hypertension
May 29, 2009
United Therapeutics has received FDA clearance to market Adcirca, its pulmonary arterial hypertension (PAH) drug.